‘One Billion Doses On Day One’: Vaccine Company Claims World-Changing Innovation
Curious about what motivates the company that just acquired UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices? Anger at the length of time it is taking to get vaccines to fight Covid. This story in Forbes is a picture of Resilience, a new player in the town of Alachua.
AI Model To Hasten Clinical Trials, Boost Medical Decision-Making, Thanks to UF Health, NVIDIA
Researchers with the University of Florida’s academic health center — UF Health — announced today that they have collaborated with NVIDIA researchers to create GatorTron™, an artificial intelligence transformer natural language processing model intended to accelerate research and medical decision-making by extracting insights from massive volumes of clinical data with unprecedented speed and clarity.
UF Health Study Will Examine Drugs To Treat Coronavirus UK Variant
Researchers say they aren't surprised by the coronavirus's ability to mutate, but they are working on ways to stop the spread. UF Associate Professor of Pathology David A. Ostrov's discovery about the UK variant has identified 40 candidate drugs that could serve as additional tools in the fight against COVID.
TeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy Program
AGTC will provide TeamedOn with the clinical trial material, pre-clinical and clinical data generated for the development of AGTC’s investigational intravitreal gene therapy candidate, rAAV2tYF-CB-hRS1
Sid Martin Biotech Alum DiaCarta’s Biomarker Algorithm Predicts Response and Outcome of Chemotherapy
UF Innovate | Sid Martin Biotech alum DiaCarta Inc., a precision molecular diagnostics company with proprietary technologies for the development of novel liquid biopsy oncology tests, announced the publication of a study in Nature Scientific Reports that demonstrates the company's cfDNA biomarker algorithm could function as a prognostic biomarker and efficacy predictor for non-small cell lung cancer (NSCLC) patients.
Resilience Acquires Biologics Manufacturing Company Ology Bioservices
Resilience, a company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired Ology Bioservices, Inc., a privately held company that also specializes in biologic drug substance manufacturing from early-stage through commercial products.
Concept Companies Developing Momentum Labs Biotech Facility
Momentum Labs in Alachua will be the next step for companies graduating from Sid Martin Biotech that need more time before investing in their own space and equipment.
Florida Blueberry Season Is Here, As Is a New Blueberry Variety From the University of Florida
April is Florida blueberry season, a time to savor these sweet fruits from our very own soil. You can pick them yourself or buy them from the store or market. The University of Florida developed and released another tasty blueberry variety to add to the seasonal mix.
UF Researchers Use AI To Breed Tastier Strawberries
University of Florida researchers are showing artificial intelligence can help scientists breed more flavor into fruit.
‘Mop Up’ Malaria Vaccine Advances to Trials in People
University of Florida researcher Rhoel Dinglasan, Ph.D., was awarded $6 million by the Global Health Innovative Technology Fund to test a new malaria vaccine in people.
